Pharsight

Flovent Hfa patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7832351 GLAXO GRP LTD Actuation indicator for a dispensing device
Jun, 2023

(3 months ago)

US7832351

(Pediatric)

GLAXO GRP LTD Actuation indicator for a dispensing device
Dec, 2023

(2 months from now)

US7500444 GLAXO GRP LTD Actuation indicator for a dispensing device
Feb, 2026

(2 years from now)

US7500444

(Pediatric)

GLAXO GRP LTD Actuation indicator for a dispensing device
Aug, 2026

(2 years from now)

Flovent Hfa is owned by Glaxo Grp Ltd.

Flovent Hfa contains Fluticasone Propionate.

Flovent Hfa has a total of 4 drug patents out of which 1 drug patent has expired.

Expired drug patents of Flovent Hfa are:

  • US7832351

Flovent Hfa was authorised for market use on 14 May, 2004.

Flovent Hfa is available in aerosol, metered;inhalation dosage forms.

The generics of Flovent Hfa are possible to be released after 26 August, 2026.

Drugs and Companies using FLUTICASONE PROPIONATE ingredient

Market Authorisation Date: 14 May, 2004

Treatment: NA

Dosage: AEROSOL, METERED;INHALATION

How can I launch a generic of FLOVENT HFA before it's drug patent expiration?
More Information on Dosage

FLOVENT HFA family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic